Literature DB >> 14970749

The distribution of white blood cell fat oxidation in health and disease.

D R Pendergast1, N M Fisher, K Meksawan, M Doubrava, G D Vladutiu.   

Abstract

Fat oxidation is important for maintaining health and for supplying energy for exercise. We have proposed that the predisposition for individual rates of fat oxidation is determined genetically but may be modulated by acute exercise or exercise training. The purpose of this study was to examine cellular fat oxidation in white blood cells (WBC) using [9,10-3H]palmitic acid. Sedentary controls free of symptoms (SED-C, n=32), were compared with known carnitine palmitoyltransferase (CPT) II-deficient patients (n =2), patients with fatiguing diseases (chronic fatigue syndrome, CFS, n=6; multiple sclerosis, MS, n=31), obesity (OB, n=5), eating disorders (ED, n=16), sedentary individuals prior to and after exercise (SED-Ex, n=12), exercise-trained sedentary individuals (SED-Tr, n=12), and elite runners (ER, n=5). Fat oxidation in WBC for all subjects was normally distributed (mean=0.270 +/- 0.090 nmol/h per 10(9) WBC) and ranged from 0.09 nmol/h per 10(9) WBC in CPT II-deficient patients to 0.59 nmol/h per 10(9) WBC in ER. There were no significant sex or acute exercise effects on WBC fat oxidation. Patients with MS, OB or ED were not different from SED-C; however, in CPT II-deficient patients, fat oxidation was low, while that of CFS patients was high. Exercise training in SED-C resulted in a 16% increase in fat oxidation but in ER it was still 97% higher than in SED-C. We propose that while WBC fat oxidation is not significantly affected by sex or acute exercise, and only by 15-20% with training, genetic factors play a role in determining both high and low fat oxidation in certain groups of individuals. The genetic predisposition for individual rates of fat oxidation may be easily measured using WBC fat oxidation, as has been shown for CPT II-deficient patients and for elite runners. Ranges of WBC fat oxidation that are abnormally low (<20 nmol/h per 10(9) WBC, normal 20-35) or high (>35 nmol/h per 10(9) WBC) are proposed based on genetic factors evaluated in this study.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14970749     DOI: 10.1023/B:BOLI.0000016637.43041.a3

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  17 in total

1.  Muscle structure with low- and high-fat diets in well-trained male runners.

Authors:  H Hoppeler; R Billeter; P J Horvath; J J Leddy; D R Pendergast
Journal:  Int J Sports Med       Date:  1999-11       Impact factor: 3.118

Review 2.  Metabolic diseases: the environment determines the odds, even for genes.

Authors:  Ingrid Schmidt
Journal:  News Physiol Sci       Date:  2002-06

3.  Influence of the level of dietary lipid intake and maximal exercise on the immune status in runners.

Authors:  J T Venkatraman; J A Rowland; E Denardin; P J Horvath; D Pendergast
Journal:  Med Sci Sports Exerc       Date:  1997-03       Impact factor: 5.411

4.  Effects of chronic intense exercise training on the leukocyte response to acute exercise.

Authors:  J A Ndon; A C Snyder; C Foster; W B Wehrenberg
Journal:  Int J Sports Med       Date:  1992-02       Impact factor: 3.118

5.  Octanoate and palmitate beta-oxidation in human leukocytes: implications for the rapid diagnosis of fatty acid beta-oxidation disorders.

Authors:  R J Wanders; L Ijlst; E van Elk; J B de Klerk; H Przyrembel
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

Review 6.  A perspective on fat intake in athletes.

Authors:  D R Pendergast; J J Leddy; J T Venkatraman
Journal:  J Am Coll Nutr       Date:  2000-06       Impact factor: 3.169

7.  Leukocyte energy metabolism. 3. Anaerobic and aerobic ATP production and related enzymes.

Authors:  M Jemelin; J Frei
Journal:  Enzymol Biol Clin (Basel)       Date:  1970

8.  Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis.

Authors:  F Lu; M Selak; J O'Connor; S Croul; C Lorenzana; C Butunoi; B Kalman
Journal:  J Neurol Sci       Date:  2000-08-15       Impact factor: 3.181

9.  Phenotypic variability among first-degree relatives with carnitine palmitoyltransferase II deficiency.

Authors:  Georgirene D Vladutiu; Michael J Bennett; Nadine M Fisher; David Smail; Richard Boriack; John Leddy; David R Pendergast
Journal:  Muscle Nerve       Date:  2002-10       Impact factor: 3.217

10.  Reduced oxidative muscle metabolism in chronic fatigue syndrome.

Authors:  K K McCully; B H Natelson; S Iotti; S Sisto; J S Leigh
Journal:  Muscle Nerve       Date:  1996-05       Impact factor: 3.217

View more
  2 in total

Review 1.  Influence of exercise on nutritional requirements.

Authors:  D R Pendergast; K Meksawan; A Limprasertkul; N M Fisher
Journal:  Eur J Appl Physiol       Date:  2010-11-16       Impact factor: 3.078

2.  Statin therapy depresses total body fat oxidation in the absence of genetic limitations to fat oxidation.

Authors:  N M Fisher; K Meksawan; A Limprasertkul; P J Isackson; D R Pendergast; G D Vladutiu
Journal:  J Inherit Metab Dis       Date:  2007-04-05       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.